MedRx Co. Ltd. announced consolidated earnings results for the first quarter ended March 31, 2018. For the quarter, the company reported Net sales of JPY 0 million compared to JPY 18 million a year ago. Operating loss was JPY 298 million compared to JPY 212 million a year ago. Ordinary loss was JPY 310 million compared to JPY 222 million a year ago. Loss attributable to owners of parent was JPY 292 million compared to JPY 192 million a year ago. Net loss per share was JPY 31.13 compared to JPY 22.61 a year ago.

For the six months ending June 2018, the company expects consolidated net sales to be JPY 0 million. Operating loss to be JPY 811 million. Ordinary loss to be JPY 809 million. Loss attributable to owners of parent to be JPY 793 million. Net loss per share to be JPY 89.21.

For the year ending December 2018, the company expects consolidated net sales to be JPY 698 million. Operating loss to be JPY 1,120 million. Ordinary loss to be JPY 1,115 million. Loss attributable to owners of parent to be JPY 1,100 million. Net loss per share to be JPY 123.79.